This is an aptamer development services to screening aptamers binds to the B3GNT9 with an affinity of 1nM~1μM.
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
| Target Category | Protein |
| Target | B3GNT9 |
| Alternative Names | UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 9; Beta-1,3-N-Acetylglucosaminyltransferase 9; Beta-1,3-Gn-T9; Beta3Gn-T9; BGnT-9; Beta-1,3-Galactosyltransferase-Related Protein; MGC4655; B3GNT9 |
| Gene ID | 84752 |
| UniProt ID | Q6UX72 |
| Target Overview | B3GNT9 (UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 9) is a Protein Coding gene. Diseases associated with B3GNT9 include Nonaka Myopathy. Among its related pathways are O-linked glycosylation and Metabolism of proteins. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring glycosyl groups and galactosyltransferase activity. An important paralog of this gene is B3GNT7. |
| Chemical Modification | N/A |
| Type | DNA |
| Length | 20-80 nt |
| Affinity (Kd) | 1nM~1μM |
| Binding Conditions/Buffer | PBS; buffer system with Serum; other |